RUNX1 Antibody

Aliases: Acute myeloid leukemia 1; Acute myeloid leukemia 1 protein; alpha subunit core binding factor; AML 1; AML1; AML1 EVI 1; AML1 EVI 1 fusion protein; Aml1 oncogene; AMLCR 1; AMLCR1; CBF alpha 2; CBF-alpha-2; CBFA 2; CBFA2; Core binding factor alpha 2 subunit; Core binding factor runt domain alpha subunit 2; Core-binding factor subunit alpha-2; EVI 1; EVI1; HGNC; Oncogene AML 1; Oncogene AML-1; OTTHUMP00000108696; OTTHUMP00000108697; OTTHUMP00000108699; OTTHUMP00000108700; OTTHUMP00000108702; PEA2 alpha B; PEA2-alpha B; PEBP2 alpha B; PEBP2-alpha B; PEBP2A2; PEBP2aB; Polyomavirus enhancer binding protein 2 alpha B subunit; Polyomavirus enhancer-binding protein 2 alpha B subunit; Run1; Runt related transcription factor 1; Runt-related transcription factor 1; RUNX 1; Runx1; RUNX1_HUMAN; SL3 3 enhancer factor 1 alpha B subunit; SL3-3 enhancer factor 1 alpha B subunit; SL3/AKV core binding factor alpha B subunit; SL3/AKV core-binding factor alpha B subunit
Antibody Type: Polyclonal Antibody
Antigen Species: Human
Uniprot ID: Q01196
Antigen: Synthesized peptide derived from Human RUNX1 around the non-phosphorylation site of S249.
Host Species: Rabbit
Species Reactivity: Human, Mouse, Rat
Tested Applications: WB, IHC, ELISA; WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:40000
Clonality: Polyclonal
Isotype: IgG
Purification Method: Antigen affinity purification
Conjugate: Non-conjugated
Buffer: PBS, 50% glycerol, 0.5% BSA, 0.02% sodium azide, pH 7.4.
Form: Liquid
Stroage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Name: RUNX1
Research Area: Neuroscience